tenk.fyi

Aura Biosciences, Inc.

AURANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$106.2M

22.2% YoY

EPS

$-1.76

0.6% YoY

Cash

$59.5M

87.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro